Proteomics Market Size, Share, Growth Analysis, By Instrumentation Technology, By Reagent, By Application, By Region - Industry Forecast 2024-2031

Global Proteomics Market size was valued at USD 25.2 billion in 2022 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031).

According to SkyQuest's analysis, there will be 19.3 million new cancer cases worldwide and 10 million cancer-related deaths. Cardiovascular diseases (CVDs) remain one of the leading causes of death globally. The World Health Organization (WHO) reports that target diseases kill 41 million people annually. Consequently, the rising prevalence of life-threatening diseases is driving the demand for personalized therapies, positively impacting the industry. The growing prevalence of chronic diseases such as cancer, CVDs, respiratory diseases, and chronic kidney disease (CKD) is also expected to fuel market growth. Increased investments in proteomics research and development are another key growth driver. The National Institutes of Health (NIH) in the United States allocated $37 billion for biomedical research, aiming to support life sciences research that seeks to understand fundamental disease processes, such as identifying biomarkers and the genes/proteins responsible for diseases. Additionally, the Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to $1.5 million to establish a mass spectrometry facility, advancing protein research significantly. The Global Proteomics Market is expected to gain momentum as activities resume following the disruptions caused by the pandemic.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Proteomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Proteomics Market Segmental Analysis

The global proteomics market is segmented based on the Instrumentation Technology, Reagent, Software &Services, Application, End User and Region. Based on the Instrumentation Technology, the market is segmented into Services, Reagents & Consumables, and Instruments. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Other Reagents. Based on Software & Services, the market is segmented into Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomics Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Services, Bioinformatics Tools, Bioinformatics Databases), Photonic Network, Other Technologies. Based on Application, the market is segmented into Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Autoimmune Diseases, Cardiovascular Diseases, Other Clinical Diagnostic Applications), Drug Discovery & Development (Target Discovery, Lead Identification, Preclinical Studies), and Other Applications. Based on End User, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories, and Other End Users. Based on Region, the market is segmneted into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Proteomics Market

The growth of the proteomics market is driven by advancements in technologies such as mass spectrometry and complex chromatography, which enhance the precision and speed of protein analysis. These innovations facilitate the identification and quantification of proteins, thereby expanding the application of proteomics in areas such as drug discovery, diagnostics, and clinical settings.

Restraints in the Global Proteomics Market

A challenge associated with proteomic data analysis is its inherent complexity. The process of examining proteomic data can be time-consuming, labor-intensive, and often requires extensive tools, as well as significant time and expertise to operate these tools effectively. This complexity can slow down the research process and potentially diminish the benefits of proteomics for both clinical and research applications.

Market Trends of the Global Proteomics Market

Nano proteomics has emerged from the integration of proteomics technologies with nanotechnology. This field leverages various nano-based approaches, including phosphor proteomics with metal oxide nanoparticles, protein microarrays, and nanostructured surfaces for protein and biomarker detection. Nano proteomics combines traditional proteomics techniques with nanotechnology applications, such as nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures, to enhance analytical capabilities and improve detection and separation of proteins.